Cancer
Cardiomyopathy
Cystic Fibrosis
Fabry Disease
Familial Thoracic Aortic Aneurysms and Aortic Dissections (TAAD)
Hearing Loss
Marfan and Loeys-Dietz Syndromes
Noonan Spectrum Disorders

• Cardio-Facio-Cutaneous (CFC) Syndrome
• Costello Syndrome
• LEOPARD Syndrome
• Noonan Syndrome

Transthyretin Amyloidosis
Warfarin Metabolism Panel

Some of our test prices have changed as of October 1, 2009. Here is our updated price list.

---

CANCER GENE TESTS

Germline Cancers

Familial Adenomatous Polyposis (FAP) and FAP-Like Syndromes
• APC Gene Sequencing Test
• APC Deletion/Duplication Analysis

Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and Related Syndromes
• MLH1/MSH2/MSH6 Gene Sequencing Tests
• MLH1/MSH2 Deletion/Duplication Analysis

Li-Fraumeni Syndrome
• TP53 Gene Sequencing Test

Von Hippel-Lindau Syndrome
• VHL Gene Sequencing Test
• VHL Deletion/Duplication Analysis

Somatic Cancers

Non-Small Cell Lung Cancer (NSCLC) Drug Responsiveness (gefitinib (Iressa®), erlotinib (Tarceva®), tyrosine kinase inhibitors)

• EGFR (Epidermal growth factor receptor) Kinase Domain Sequencing Test

Cancer Gene Tests (for researchers only)
• BRAF
• ERBB2
• KRAS2

CARDIOMYOPATHY GENE TESTS

Dilated Cardiomyopathy (DCM)
• DCM CardioChip (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, LMNA , ACTC, PLN , LDB3, TAZ, ABCC9, ACTN2, CSRP3, CTF1, DES, EMD, SGCD, TCAP, and VCL)

Hypertrophic Cardiomyopathy (HCM)
• HCM CardioChip (MYH7, MYBPC3, TNNT2, TNNI3, TPMI, ACTC, MYL2, MYL3, LAMP2, PRKAG2, and GLA)

Unexplained Cardiac Hypertrophy (Danon disease, Glycogen storage cardiomyopathy)
• LAMP2 and PRKAG2 Gene Panel
• GLA Gene Test

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C)
• ARVD/C Panel (DSP, DSG2, DSC2, PKP2, TMEM43)

Cystic Fibrosis

• CFTR Full Gene Sequencing Test

Fabry Disease

• GLA Gene Test

Familial Thoracic Aortic Aneurysms and Aortic Dissections (TAAD)

• ACTA2 Gene Test
• TGFβR2 Gene Test
• TGFβR1 Gene Test
• FBN1 Gene Test

HEARING LOSS GENE TESTS

TEST PANELS (These genes are also available as individual gene tests)


• Non-syndromic hearing loss and Usher syndrome
• OtoChip (CDH23, CLRN1, DFNB31 (WHRN), GJB2, GJB6, GPR98 (VLGR1) (partial), MTRNR1 (12S rRNA), MTTS (tRNAser^(UCN)), MYO6, MYO7A, OTOF, PCDH15, SLC26A4 (PDS), TMC1, TMIE, TMPRSS3, USH1C, USH1G (SANS), USH2A)
• Connexin Test
• Ashkenazi Jewish Hearing Loss Panel (35delG & 167delT in GJB2, GJB6-D13S1830 deletion, R245X in PCDH15, N48K in CLRN1)
  


• Aminoglycoside-Induced or Maternally-Inherited Hearing Loss
• Mitochondrial Gene Panel (MTRNR1 (12S rRNA), MTTS1 (tRNAser^(UCN)))
  

INDIVIDUAL GENE TESTS (Some of these genes are also included on the test panels)


• Auditory Neuropathy/Dys-synchrony
• OTOF Gene Test (for DFNB9/Auditory Neuropathy/Dys-Synchrony)
  


• Pendred Syndrome/ Hearing Loss with EVA/Mondini Dysplasia
• SLC26A4 (PDS) Gene Test
  


• Usher Syndrome (Hearing loss and retinitis pigmentosa)
• Type I (MYO7A, USH1C, CDH23, PCDH15, USH1G (SANS))
  
• Type II (USH2A, GPR98 (VLGR1), DFNB31 (WHRN))
  
• Type III (CLRN1)
  


• Vohwinkel syndrome (Hearing loss and skin defects) (GJB2)
• Connexin 26 (GJB2) Gene Test
  


• X-Linked Nonsyndromic Hearing Loss
• POU3F4 Gene Test
  


• Dominant Hearing Loss
• COCH Gene Test (DFNA9) - onset 15-65 years with vestibular problems
  
• Connexin 26 (GJB2) Gene Test - onset 0-20 years
  
• MYO7A Gene Test (for DFNA11) - onset 10-60 years and nonsyndromic
  

Marfan and Loeys-Dietz Syndromes

• FBN1 Gene Test
• This gene test may also be appropriate for other fibrillinopathies such as MASS syndrome.
• TGFβR1 Gene Test
• TGFβR2 Gene Test

Noonan Spectrum Disorders
(Cardio-Facio-Cutaneous (CFC) Syndrome, Costello Syndrome, LEOPARD Syndrome, Noonan Syndrome)

• Noonan Spectrum Chip (PTPN11, SOS1, RAF1, KRAS, BRAF, MEK1, MEK2 + HRAS)

Transthyretin Amyloidosis

• TTR Gene Test

Warfarin Metabolism Panel

• VKOR1 and CYP2C9 Genotyping